PMV Pharmaceuticals, Inc. (PMVP) vs Rallybio Corporation (RLYB)

A side-by-side comparison of PMV Pharmaceuticals, Inc. and Rallybio Corporation across valuation, profitability, dividends, and growth — built entirely from reported fundamentals, as of October 6, 2026. Differences are shown without an overall score or investment verdict.

Compare

Total return — PMVP vs RLYB

growth of $100 · dividends reinvested · last 5y
PMVP -95.0% (-45.1%/yr)RLYB -85.0% (-31.6%/yr)RLYB compounded faster over this window
050100Start $10020222023202420252026$5$15
PMVP RLYB

PMVP vs RLYB: by the numbers

  • •RLYB is the larger company ($90M vs $90M market cap).
  • •RLYB is profitable (7051.24% net margin) while PMVP runs a net loss (0.00%).

Metrics side by side

Valuation

MetricPMVPRLYB
P/E ratioN/A2.18
P/S ratioN/A139.82
P/B ratio1.250.96
FCF yieldN/A29.16%

Profitability

MetricPMVPRLYB
Gross margin0.00%89.28%
Operating margin0.00%-3270.86%
Net margin0.00%7051.24%
ROE-105.20%48.20%
ROIC-111.42%-24.40%

Growth (annualized)

MetricPMVPRLYB
Total return CAGR (5Y)-43.17%-35.80%

Frequently asked

Is PMVP or RLYB more profitable?
RLYB runs the higher net margin — PMVP at 0.00% versus RLYB at 7051.24%.
How have PMVP and RLYB total returns compared?
Over the past 5 years, PMVP delivered -43.17% and RLYB delivered -35.80% annualized total return. Past performance doesn't predict future results.

Figures are sourced from reported fundamentals and the latest end-of-day price. This comparison is informational only and is not investment advice. Past performance does not predict future results. See our methodology. Compiled by TGMCharts Research · data verified October 6, 2026.